Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending March 24
Ally Financial, NFL, Papa Johns, Overair, LastPass, Curbio, Hinge Health, Momnt, Sealed Air, Infobip
By
Lauren Muskett
| March 24, 2023
Read More
Resources
Reports
Reports
2023
2022
Featured
People
CFOs On the Move: Week Ending March 24
Ally Financial, NFL, Papa Johns, Overair, LastPass, Curbio, Hinge Health, Momnt, Sealed Air, Infobip
By
Lauren Muskett
| March 24, 2023
Read More
Sign Up
Menu
Reports
2023
2022
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
Sign Up
Sponsored by
Roche
Strategy
Roche Takes Full Control of Genomic Profiler
The $2.4 billion purchase of 44% of Foundation Medicine raises Roche's bet on the development of personalized cancer treatments and care.
By
Matthew Heller
| June 19, 2018
Read More
Technology
Roche Buys Flatiron in $1.9B ‘Big Data’ Move
The real-world evidence Flatiron's record system collects "is a key ingredient to accelerate the development of, and access to, new cancer treatments."
By
Matthew Heller
| February 15, 2018
Read More
People
Facebook CFO: “Wicked Smart,” But No Ego
David Ebersman is perfectly suited for the maelstrom to come when the social-media giant's IPO hits the market.
By
David McCann
| February 2, 2012
Read More